Moderna Inc. (NASDAQ:MRNA) stock plunged more than 25% Thursday after the alleged leak of an ESMO 2026 conference abstract raised concerns about the effectiveness of its experimental personalized mela[...]
By using this site, you agree to the storage of cookies on your device for enhanced navigation, site analysis, and The TradingPub's marketing. Data sharing with social media platforms might occur based on the privacy choices you make on those platforms. For specifics, see our Privacy Policy.
